Onychomycosis: Diagnosis and management

A Singal, D Khanna - Indian journal of dermatology, venereology and …, 2011 - ijdvl.com
Onychomycosis is a common nail ailment associated with significant physical and
psychological morbidity. Increased prevalence in the recent years is attributed to enhanced …

Onychomycosis: evaluation, treatment options, managing recurrence, and patient outcomes

TC Vlahovic - Clinics in podiatric medicine and surgery, 2016 - podiatric.theclinics.com
Onychomycosis is a common superficial fungal infection of the nails leading to discoloration,
nail plate thickening, and onycholysis. Mycotic nail disease is the most common nail …

British Association of Dermatologists' guidelines for the management of onychomycosis 2014

M Ameen, JT Lear, V Madan… - British Journal of …, 2014 - academic.oup.com
The clinical signs of tinea unguium are often difficult to distinguish from those of a number of
other infectious causes of nail damage, such as Candida, mould or bacterial infection. 5 …

Amorolfine vs. ciclopirox–lacquers for the treatment of onychomycosis

K Tabara, AE Szewczyk, W Bienias… - … in Dermatology and …, 2015 - termedia.pl
Abstract Amorolfine 5% and ciclopirox 8% nail lacquers are commonly used in topical
treatment of onychomycosis. These formulations may be used alone or in combination with …

Efficacy and safety of luliconazole 5% nail solution for the treatment of onychomycosis: a multicenter, double‐blind, randomized phase III study

S Watanabe, H Kishida, A Okubo - The Journal of Dermatology, 2017 - Wiley Online Library
Onychomycosis is a highly prevalent and intractable disease. The first‐line treatment agents
are oral preparations, but an effective topical medication has long been desired. The …

The safety of oral antifungal treatments for superficial dermatophytosis and onychomycosis: a meta-analysis

CH Chang, Y Young-Xu, T Kurth, JE Orav… - The American journal of …, 2007 - Elsevier
PURPOSE: We estimated the absolute risks of treatment termination and incidence of
adverse liver outcomes among all commonly used oral antifungal treatments for superficial …

Combination therapy should be reserved as second-line treatment of onychomycosis: a systematic review of onychomycosis clinical trials

JM Falotico, R Lapides, SR Lipner - Journal of Fungi, 2022 - mdpi.com
Onychomycosis is the most common nail disease encountered in clinical practice. Its
importance extends well beyond aesthetics, often causing pain, difficulty with ambulation …

Pharmacoeconomics–an aid to better decision‐making

R Arenas‐Guzman, A Tosti, R Hay… - Journal of the …, 2005 - Wiley Online Library
Objectives The first aim of this workshop was to define pharmacoeconomic concepts and
terminology. Pharmacoeconomics can be defined as the branch of economics that uses cost …

Efficacy of long‐term treatment with efinaconazole 10% solution in patients with onychomycosis, including severe cases: a multicenter, single‐arm study

K Iozumi, M Abe, Y Ito, T Uesugi… - The Journal of …, 2019 - Wiley Online Library
We evaluated the efficacy of efinaconazole 10% topical solution in long‐term use, for up to
72 weeks, for onychomycosis, including severe cases. Among 605 participants, 219 patients …

Non‐dermatophyte fungi in onychomycosis—Epidemiology and consequences for clinical practice

D Reinel - Mycoses, 2021 - Wiley Online Library
Onychomycoses are difficult‐to‐treat fungal infections with a high recurrence rate that
relates to the anatomic and pathophysiological conditions in the nail organ and the required …